Evaluating the efficacy of drug combinations in treating MRSA: A systematic review

Clicks: 2
ID: 284731
2024
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #3,530 of 3,757 articles by views in Malay Journal

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 3,757 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Methicillin-resistant Staphylococcus aureus (MRSA) is a significant pathogen due to its resistance to standard antibiotics, necessitating the exploration of alternative treatments. Increased rates of morbidity and mortality have resulted from this resistance, especially in healthcare settings where infections can spread quickly. Therefore, the development and evaluation of effective drug combinations are essential for preventing MRSA infections and enhancing patient outcomes. Taking these points into account, this study aimed to evaluate the efficacy of various drug combinations in treating MRSA, specifically to assess the outcome of drug combinations utilized in the treatment of MRSA. These outcomes include whether the patients were (a) treated or not treated ; (b) if not treated it led to death or gain more resistance to various drugs or lead to other complications, and to identify the different drug combinations used in the treatment of MRSA. The investigation included 33 articles published between January 2014 and March 2024 from three databases, focusing on antibiotic and natural product combinations. After the 33 publications were examined, favorable findings were found. All 33 studies (100%) showed high success and recovery rates while also successfully eradicating the infection. Interestingly, no resistance developed in twenty-five (25) out of 33 studies (75.76%). Moreover, eight studies (24.24%) revealed a decrease in resistance. Thirty-three (33) studies (100%) reported no deaths and five studies (15.15%) indicated a reduction in mortality. In terms of complications, 25 articles (75.76%) reported no adverse effects, while 6 articles (18.18%) showed a decrease in complications. Nine (9) out of 33 studies (27.27%) highlighted that combining daptomycin with various other drugs effectively inhibits MRSA, demonstrating its role in synergistic combinations. The study did, however, also highlight the drawbacks of depending just on research that has been published, the possibility of publication bias, and the requirement for a more thorough investigation incorporating patient data. The findings open the door for more therapeutic uses and highlight the value of combination treatments in treating MRSA infections.
Reference Key
persistent_1760653517_68f170cd0c406 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Pecson, Matthew Robyn G.
Journal Malay Journal
Year 2024
DOI
DOI not found
URL
https://animorepository.dlsu.edu.ph/etdb_bio/86
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.